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The fate of differentiating MSCs influences the development of obesity and osteoporosis. Jiang et al. report that SHP1 controls MSC differentiation through binding to GSK3b and suppressing its kinase activity. These findings reveal a role for SHP1 in controlling bone and fat mass by modulating MSC differentiation.
SUMMARY
Osteoblasts and adipocytes are derived from a common precursor, mesenchymal stem cells (MSCs). Alterations in the normal fate of differentiating MSCs are involved in the development of obesity and osteoporosis. Here, we report that viable motheaten (me v ) mice, which are deficient in the SH2-domaincontaining phosphatase-1 (SHP1), develop osteoporosis spontaneously. Consistently, MSCs from me v /me v mice exhibit significantly reduced osteogenic potential and greatly increased adipogenic potential. When MSCs were transplanted into nude mice, SHP1-deficient MSCs resulted in diminished bone formation compared with wild-type MSCs. SHP1 was found to bind to GSK3b and suppress its kinase activity by dephosphorylating pY216, thus resulting in b-catenin stabilization. Mice, in which SHP1 was deleted in MSCs using SHP1 fl/fl Dermo1-cre, displayed significantly decreased bone mass and increased adipose tissue. Taken together, these results suggest a possible role for SHP1 in controlling tissue homeostasis through modulation of MSC differentiation via Wnt signaling regulation.
INTRODUCTION
Mesenchymal stem cells (MSCs) are multipotent and can differentiate into one of several distinct cell lineages under appropriate conditions, including cartilage-forming chondrocytes (Wu et al., 2013) , bone-forming osteoblasts (Pittenger et al., 1999) , and fat-forming adipocytes, as well as myoblasts, fibroblasts, skeletal muscle cells (Moroni and Fornasari, 2013) , and neurogenic lineages (Chamberlain et al., 2007) . In addition, several studies have demonstrated an inverse relationship between adipogenesis and osteogenesis (James et al., 2012; Pei and Tontonoz, 2004 ). An imbalance between adipogenesis and osteogenesis can lead to various metabolic disorders, including osteoporosis, osteopetrosis, and obesity (Uccelli et al., 2008) . MSC differentiation is influenced by several key lineagespecific transcription factors: C/EBPa, C/EBPb, and C/EBPd (CCAAT/enhancer-binding proteins) (Darlington et al., 1998) , as well as PPARg (peroxisome proliferation-activated receptor g) (Zhang et al., 2010) , are critical for adipogenesis, while Runx2 (Runt-related transcription factor 2) (Neve et al., 2011 ) is vital for osteoblast differentiation. Indeed, several intrinsic signaling pathways that regulate the expression of lineage-specific transcription factors have been shown to guide MSC differentiation toward either the osteoblast or adipocyte lineages, including Wnt/b-catenin signaling. Activation of Wnt/b-catenin signaling in MSCs favors osteogenesis at the expense of adipogenesis by modulating the availability of cell-type-specific transcription factors (Bennett et al., 2005) . Conversely, disruption of Wnt/b-catenin signaling leads to spontaneous adipogenesis by MSCs and pre-adipocytes. Wnt/b-catenin signaling regulates the fate of MSCs by suppressing adipocyte transcription factors, by stimulating the production of osteoblast transcription factors, or by both mechanisms (Bennett et al., 2005) .
The Src homology protein, SHP1 is predominantly expressed in hematopoietic cells. SHP1 is traditionally considered to negatively regulate hematopoietic and immune cell function (Shultz et al., 1997) . However, its role in stem cells and some progenitor cells has only recently been described. SHP1 has been shown to participate in modulating the stemness of mouse embryonic stem cells (ESCs) (Cha et al., 2010) and to be involved in neuronal differentiation (Mizuno et al., 1997) . SHP1 activity is completely absent in the murine motheaten mutation (me/me), whereas the viable motheaten mutation (me v /me v ) retains about 25% of SHP1 activity. Both of these mutants exhibit classic symptoms of osteoporosis (Green and Shultz, 1975) , including significantly lower bone marrow density and mineral content in the femur, compared to wild-type (WT) mice, although the mechanism is not clear.
It has been suggested that osteoporosis results from imbalanced differentiation of MSCs into either osteoblasts or adipocytes. In the present study, we investigated whether osteoporosis observed in SHP1-deficient mice is due to a cellautonomous function of SHP1 in MSC differentiation. We find that SHP1 promotes osteogenesis and inhibits adipogenesis in MSCs by modulating Wnt/b-catenin signaling. Importantly, we generated SHP1
fl/fl Dermo1-cre mice that induce a targeted deletion of SHP1 specifically in MSCs during mesenchymal condensation, which precedes osteogenesis and adipogenesis (Plutzky et al., 1992) . These mice were found to have less bone and more fat tissue as adults, consistent with the phenotype in SHP1-deficient MSCs. Thus, we present compelling evidence that SHP1 plays an important role in regulating the formation of bone mass and adipose tissue by MSCs. (Aoki et al., 1999) . It has also been demonstrated that bone density in the cortex and spongiosa is lower in me v /me v mice compared with littermate controls (Umeda et al., 1999) . To reproduce these previous findings, bones from me v /me v and WT male mice were analyzed by micro-computed tomography (mCT). mCT analysis of the cortical bone and trabecular bone in the proximal tibia revealed much lower bone mass in me v /me v mice ( Figure 1A ).
RESULTS
The trabecular bone-volume/tissue-volume ratio (BV/TV) was over 50% lower in the me v /me v group, compared with WT controls, and was accompanied by 40% lower bone mineral density (BMD), 30% less trabecular thickness (Tb.Th), 60% lower trabecular number (Tb.N), and more than 50% greater trabecular separation (Tb.Sp) ( Figure 1B ). The structure model index (SMI), which quantifies 3D structure for the relative amounts of plates and rods (SMI = 0, strong bone; SMI = 3, fragile bone), was about 50% higher ( Figure 1B (Heino and Hentunen, 2008) . Therefore, we measured protein levels of SHP1 in differentiating MSCs isolated from WT mice, following an established protocol (Ren et al., 2008) . Interestingly, SHP1 levels were observed to increase when MSCs were subjected to osteogenic differentiation conditions, while they decreased under adipogenic differentiation conditions ( Figure 2A ). SHP2, another member of the Src homology phosphatase family that is also known to regulate adipose tissue formation (He et al., 2013) , was also measured and found to be expressed at similar levels during both osteogenic and adipogenic differentiation (Figure 2A ). To confirm that SHP1 is involved in the process of MSC differentiation, bone marrow MSCs from me v /me v and WT mice were monitored during culture for their expression of MSC-specific phenotypic markers (Sung et al., 2008 Figure 2C ). This suggests that SHP1 plays a key role in controlling the fate of differentiating MSCs in vitro. Since SHP1, as a protein tyrosine phosphatase, acts by dephosphorylating its target molecules (Zhang et al., 2000) , we tested whether this enzymatic activity was involved in SHP1 function during MSC differentiation. When the compound NSC-87877, an inhibitor of SHP1 phosphatase activity, was added during WT MSC differentiation under specific conditions, significantly reduced osteogenesis and enhanced adipogenesis were observed ( Figures 2D and 2E ), and these effects were found to be dose dependent. The expression profiles of key transcription factors and differentiation markers were analyzed by real-time PCR after MSCs were subjected to specific differentiation conditions. We found that high concentrations of the SHP1 inhibitor resulted in significantly lower levels of Runx2 and associated osteogenic markers, including osteopontin (OPN), collagen 1a (Col1a), and osteocalcin (OCN) in the MSCs ( Figure 2F ). Interestingly, even with low concentrations of SHP1 inhibitor, MSCs displayed strikingly higher levels of C/EBPa and adipogenic markers, including fatty-acid-binding protein 4 (FABP4) and adiponectin ( Figure 2G ). These results indicate that the phosphatase activity of SHP1 influences MSC differentiation.
SHP1, but Not SHP2, Is Indispensable for the Normal Differentiation of MSCs Because NSC-87887 is not specific for SHP1, it might also partially inhibit SHP2 activity (Chen et al., 2015) . To parse out their effects, SHP1 and SHP2 were individually knocked down in WT MSCs; effective knockdown was achieved for both proteins ( Figures 3A and 3D ). When SHP1-knockdown MSCs were then cultured in differentiation medium, we found that adipogenic differentiation was favored over osteogenic differentiation. To better quantify this effect, the extent of the differentiated area was calculated using IMT i-Solution software, and differences in the percentage of differentiated areas were found to be highly significant ( Figures 3B and 3C ). In contrast, SHP2-knockdown MSCs displayed similar amounts of both osteogenesis and adipogenesis and little difference in calculated areas of differentiation ( Figures 3E and 3F ). To further verify the role of SHP1, MSCs were transfected with a constitutive SHP1 expression cassette, and SHP1 expression was examined by western blotting (WB) ( Figure 3G ). When these SHP1-overexpressing MSCs were cultured in the respective differentiation media, we observed enhanced osteogenesis and reduced adipogenesis compared to WT controls. Software analysis of the extent of differentiated area confirmed a significant difference ( Figures 3H and 3I MSCs formed some adipocytes but no bone mass in the HA/TCP particles ( Figure 3K ).When the areas of bone formation revealed by H&E staining were quantitated using ImageJ software, bone formation was found to be much lower in the me v /me v MSC group than in the WT MSC group at 4 or 8 weeks ( Figure 3L ).
SHP1 Modulates the Expression of Transcription Factors that Regulate Differentiation
Previous studies have shown that Runx2 plays an important role in osteogenic differentiation (Gersbach et al., 2006) and that C/EBPa, C/EBPb, and PPARg are key factors driving the adipogenic differentiation of MSCs (Cristancho and Lazar, 2011) . (F) WT MSCs were subjected to osteogenic differentiation in the presence of the inhibitor NSC-87877, and expression levels of Runx2, osteopontin (OPN), collagen 1a (Col1a), and osteocalcin (OCN) on the indicated days were analyzed by real-time PCR.
(G) WT MSCs were subjected to adipogenic differentiation, and C/EBPa, FABP4, and adiponectin were analyzed as in (F).
Bars represent means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant. After SHP1 and SHP2 were individually knocked down in WT MSCs, protein expression was analyzed by WB. We found that SHP1-knockdown MSCs expressed more C/EBPa and PPARg, but similar amounts of Runx2 and C/EBPb, in comparison to control MSCs ( Figure 4D ). In contrast, SHP2-knockdown MSCs exhibited unchanged levels of C/EBPa, C/EBPb, PPARg, and Runx2 ( Figure 4E ). We also found, conversely, that adipogenic transcription factors, including C/EBPa, C/EBPb, and PPARg, were decreased in SHP1-overexpressing MSCs, while Runx2 was increased, even under naive conditions ( Figure 4F ). These results indicate that SHP1 regulates critical transcription factors during MSC differentiation.
Signaling from Wnt, but Not BMP, Is Involved in Impaired Osteogenic Differentiation by SHP1-Deficient MSCs The Wnt and BMP signaling pathways are well known to play important roles in regulating MSC differentiation (Ling et al., 2009) . Wnt signaling through the canonical b-catenin-dependent pathways is considered pro-osteogenic and anti-adipogenic (Case and Rubin, 2010; Glass et al., 2005) . To examine whether SHP1 has a regulatory role in Wnt signaling, the expression levels of total b-catenin and non-phospho-b-catenin after treatment with Wnt3a were measured in both me v /me v MSCs and WT MSCs by WB. We observed that both total b-catenin and non-phospho-b-catenin were dramatically decreased in me v / me v MSCs compared to WT MSCs ( Figure 5A ). b-catenin phosphorylation is mediated by GSK3b, whose activity is regulated by site-specific phosphorylation; full activity of GSK-3b generally requires phosphorylation at tyrosine 216 (Tyr216); conversely, phosphorylation at serine 9 (Ser9) inhibits GSK-3b activity. Consistently, we found that GSK3b phosphorylation at Tyr216 was slightly increased, while phosphorylation at Ser9 was detectably decreased in me v /me v MSCs, although total protein levels of GSK3b were no different from those in controls (Figure 5B ). This indicates that Wnt signaling is diminished in SHP1-deficient (me v /me v ) MSCs.
To further determine how SHP1 regulates the Wnt signaling pathway, the target molecules of SHP1 had to be defined. To address this, we examined the interaction between SHP1 and GSK3b in Wnt3a-treated SHP1-overexpressing MSCs using immunoprecipitation and WB. First, the amounts of SHP1 and GSK3b were determined in whole-protein lysates of SHP1-overexpressing MSCs before and after Wnt3a treatment, normalized to GAPDH levels ( Figure 5C ). Next, immunoprecipitation with SHP1 revealed that large amounts of GSK3b coprecipitated with SHP1 in the lysates from SHP1-overexpressing MSCs both before and after Wnt3a treatment. Additional evidence of the interaction between GSK3b and SHP1 was provided by GSK3b immunoprecipitation, which resulted in the coprecipitation of SHP1 ( Figure 5C ). Additionally, small amounts of b-catenin and non-phospho-b-catenin were detected after SHP1 immunoprecipitation ( Figures S1A and S1B ). SHP1 binding of b-catenin and non-phospho-b-catenin may result from the binding of b-catenin to GSK3b. These results indicate that SHP1 regulates the Wnt signaling pathway by forming a complex with GSK3b that dephosporylates GSK3b at Tyr216, thereby inhibiting its enzymatic activity. In turn, b-catenin phosphorylation is decreased, leading to the accumulation and nuclear translocation of b-catenin, thereby activating gene expression ( Figure 5D ).
We also examined whether SHP1 is involved in the BMP signaling pathway. In this pathway, Smad4 interacts with other phosphorylated Smads to form homomeric or heteromeric complexes, which then translocate to the nucleus, where they regulate the transcription of downstream genes (Li, 2008) . When the levels of Smad4 and phosphorylated Smad1/5/9 were measured in MSCs treated with BMP2 or BMP4, no obvious difference was observed between SHP1-deficient and control MSCs (Figures S1C and S1D) . Therefore, BMP signaling is unlikely to be involved in the impaired osteogenesis observed in SHP1-deficient MSCs.
Conditional Deletion of SHP1 Interferes with Fat and Bone Formation
We have shown that inactivation of SHP1 in MSCs in vitro and in vivo results in greatly reduced osteogenic differentiation and less bone formation. To further test whether SHP1 plays an important role in bone formation, we utilized the Cre-Lox recombination system to knock out SHP1 in MSCs in vivo. SHP1 fl/fl mice were crossed with Dermo1-cre mice, in which cre activity occurs during mesenchymal condensation and later in condensed mesenchyme-derived chondrocytes and osteoblasts (Li et al., 1995) . Therefore, we predicted that SHP1
fl/fl
Dermo1-cre mice would lack SHP1 in mesenchymal progenitor cells. Indeed, we observed shorter teeth in 3-week-old SHP1 fl/fl Dermo1-cre mice ( Figure 6A ). To characterize the osteoblast differentiation defects in SHP1 fl/fl Dermo1-cre mice, femurs were analyzed by micro-CT. Insufficient development in the bone of the proximal tibia was observed in SHP1 fl/fl Dermo1-cre mice compared with control SHP1 fl/fl mice ( Figure 6B ). In addition, trabecular BV/TV was decreased by more than half, BMD was 20% lower, SMI almost doubled, Tb.Th and Tb.N were less, and Tb.Sp was increased ( Figure 6C ). Microscopic examination of H&E-stained bone sections showed that fewer trabeculae had developed in SHP1 fl/fl Dermo1-cre (G) WT MSCs were transfected by lentivirus containing an SHP1-expression vector or control vector, and SHP1 expression was measured by WB. (H and I) SHP1-overexpressing MSCs and control MSCs were cultured in differentiation medium and stained respectively with alizarin red S for osteogenesis or oil red O for adipogenesis. The stained area was quantitated using IMT i-Solution software. Scale bars, 500 mm in (H) and 100 mm in (I).
(J) MSCs were mixed with HA/TCP, incubated overnight, and the mixture was implanted subcutaneously under the dorsal skin of nude mice. After 8 weeks, the implants were removed, fixed in 4% paraformaldehyde, and analyzed by micro-CT to determine bone-volume/tissue-volume ratio (BV/TV). PBS, control HA/TCP implanted into nude mice. (K) Excised implants were paraffin embedded, sectioned, and stained with H&E, and then examined microscopically. Dotted lines delineate the boundary between bone (B) and connective tissues (CT), and the arrowheads indicate areas of bone or adipose (A) formation. HA/TCP, hydroxyapatite tricalcium phosphate. Scale bar, 500 mm. W, weeks.
(L) Based on H&E staining, the amount of bone that formed on the HA/TCP particles at 4 and 8 weeks was quantitated using ImageJ software. Bars represent mean ± SEM (n = 3). **p < 0.01; ***p < 0.001; ns, not significant. mice ( Figure 6D ). Interestingly, however, higher fat-to-bodyweight ratios and more gonadal fat tissue deposition occurred under a normal diet in both male and female SHP1 fl/fl Dermo1-cre mice, compared to SHP1 fl/fl controls, while the amounts of subcutaneous fat tissue were comparable ( Figure 6E ). The opposite tendencies of subcutaneous and gonadal fat tissue distribution in SHP1 fl/fl Dermo1-cre mice could be explained by their different mechanisms of development . The fat tissue deposition patterns reveal that SHP1 deletion affects mainly adipocyte differentiation in gonadal fat tissue. Greater fat tissue development in SHP1 fl/fl Dermo1-cre mice is consistent with the increased adipogenesis seen in SHP1-deficient MSCs. These results further illustrate that conditional deletion of SHP1 during mesenchymal condensation delays bone formation, while it enhances gonadal fat tissue formation.
DISCUSSION
Previous reports have demonstrated that systemic SHP1 deficiency in mice induces significant osteoporosis. However, the mechanism has not been conclusively determined, nor is it known whether the observed reduction in osteoblast function is directly related to a lack of SHP1. Here, we have identified SHP1 to be a critical regulator of bone mass that functions by controlling the fate of MSC differentiation, toward either an osteogenic phenotype or an adipogenic one. The effects of SHP1 on MSC differentiation are exerted through its regulation of the expression of lineage-specific transcription factors, including C/EBPs, PPARg, and Runx2, and are linked to upregulation of Wnt signaling. Osteoblasts and adipocytes are both derived from the same MSC precursors. Therefore, the effect of SHP1 deficiency on the differentiation capacity of MSCs was examined in vitro and ex vivo, using cells from SHP1-deficient mice. We found, in vitro, that SHP1-deficient MSCs have enhanced adipogenic differentiation, while osteogenic differentiation is reduced. In addition, the epitomic bone formation assay demonstrated that SHP1 is critical for controlling the differentiation of MSCs. Moreover, adipocyte formation was observed in HA/ TCP particles coated with me v /me v MSCs but not with WT MSCs. The lineage differentiation of MSCs is controlled by several specific transcription factors. Adipogenic differentiation is dependent on the C/EBP family and PPARg (Tontonoz et al., 1994) , whereas osteogenic differentiation requires chiefly Runx2 (Ducy et al., 1997) . When expression of these pivotal transcription factors during MSC differentiation was analyzed by WB and real-time PCR, the adipogenic transcription factors C/EBPa and PPARg were found to be notably increased in SHP1-deficient MSCs at both the protein and mRNA levels. The expression and activation of specific transcription factors during MSC differentiation are regulated by several signaling pathways, the most important being Wnt and BMP signaling. Most reports have shown that both of these signaling pathways promote osteogenic differentiation and inhibit adipogenic differentiation. BMP signals control MSC differentiation, mainly by regulating Runx2 expression through the canonical Smaddependent pathways and non-canonical Smad-independent pathways. BMP family members, such as BMP2, BMP4, and BMP6, have been show to induce MSC differentiation (Chen et al., 2012) . Deletion of BMP2 or BMP4 in mice leads to defects in skeletogenesis and a loss of osteogenesis (Bandyopadhyay et al., 2006) . In the present study, however, BMP signals were found to be unaffected by SHP1. The influences of the canonical Wnt/b-catenin signaling pathway on osteogenic differentiation by MSCs are complex and not yet fully elucidated. For the most part, however, canonical Wnt/b-catenin signaling is believed to favor osteogenic differentiation by MSCs, rather than adipogenesis, through inhibition of C/EBP and PPARg expression. For instance, Wnt receptor ligands, such as Wnt6, Wnt10a, and Wnt10b, are reported to promote osteogenic MSC differentiation through canonical b-catenin signaling (Baksh and Tuan, 2007) . Studies in which Wnt10b gene dosages were altered have revealed that Wnt10b is a positive regulator of bone formation, as it enhances osteoblast differentiation, and it maintains mesenchymal progenitors, osteoblast progenitors, or both in adult bone (Bennett et al., 2007; Stevens et al., 2010) . Protein phosphorylation and dephosphorylation at tyrosyl residues are important regulatory mechanisms that modulate the activity of proteins involved in the process of cell growth and differentiation. SHP1 acts as both a positive and a negative regulator of signal transduction. SHP1 was previously shown to significantly reduce b-catenin/TCF-dependent transcription in intestinal crypt epithelial cells by binding to and dephosphorylating b-catenin (Duchesne et al., 2003) . SHP1 has also been demonstrated to interfere with b-catenin activity by promoting its degradation in a GSK3b-dependent manner (Simoneau et al., 2011 (E) Subcutaneous and gonadal fat tissues were isolated from 2-month-old females (top) or males (bottom) (n = 5) and analyzed for total fat ratio and subcutaneous and gonadal fat weights. sWAT, subcutaneous white adipose tissue; gWAT, gonadal white adipose tissue. Bars represent mean ± SEM (n = 5); ns, not significant; *p < 0.05; **p < 0.01.
WNT signaling pathway (Clodfelder-Miller et al., 2005 (Soriano, 1999) , SHP1 is deleted in progenitor MSCs that can generate both osteoblast and chondrocyte lineage cells. This analysis also showed that both osteoblasts and chondrocytes, derived from condensed mesenchyme, did indeed express Dermo1-cre (Liu et al., 2010) . In addition, Dermo1-cre has been shown to be specifically expressed in bone marrow-derived MSCs (Liu et al., 2010) . Significantly, SHP1
fl/fl Dermo1-cre mice showed characteristics of osteoporosis, including fewer trabeculae and shorter teeth, because of insufficient osteoblast formation. In addition, the amount of adipose tissue in the gonads was increased. These results further illustrate that SHP1 deficiency in MSCs leads to abnormalities in bone formation.
In conclusion, this study suggests that SHP1 regulates bone and fat development in adults by influencing the balance between osteoblast differentiation and adipocyte differentiation by MSCs. The tendency toward adipogenic differentiation appears to be favored in the absence of normal SHP1, suggesting that SHP1 is a positive regulator of osteogenesis and a negative regulator of adipogenesis. Cell Culture Using our lab-developed protocol, the tibias and femurs of 6-to 10-week-old WT and age-matched me v /me v mice were dissected from the surrounding tissues, the bones were cut, and bone marrow cells were collected by flushing with low-glucose DMEM (Invitrogen). Cell cultures were incubated in a humidified environment containing 5% CO 2 at 37 C.
Reagents
Reagents for inducing MSC differentiation, including indomethacin, dexamethasone, insulin, 3-isobutyl-1-methylxanthine, L-ascorbic acids, and b-glycerophosphate, as well as alizarin red S, oil red O, and formaldehyde solution were purchased from Sigma-Aldrich. Antibodies used in WB were: SHP1 (Abcam); Runx2 (Epitomics); C/EBPa, C/EBPb, PPARg, b-catenin, GSK3b, non-phospho-b-catenin, pGSK3b, and GAPDH (Cell Signaling Technology).
Differentiation of MSCs
Accordingly, to induce osteogenic differentiation, MSCs were cultured in high-glucose DMEM supplemented with 10% heat-inactivated FBS, 10 nM dexamethasone, 100 mM L-ascorbic acid, and 10 mM b-glycerophosphate. Adipogenic differentiation was induced with high-glucose DMEM containing 0.5 mM isobutylmethylxanthin, 60 mM indomethacin, 100 nM dexamethasone, and 10 mg/ml insulin.
Histological Analysis of Differentiated BMSC Cultures
Osteogenesis was evaluated by alizarin red S staining. In brief, the cells were fixed in cold 70% ethanol for 1 hr, washed twice with H 2 O, and incubated with 2% alizarin red S (pH = 4.1 to 4.3) for about 15 min to reveal calcium deposition. Adipogenesis was assessed by oil red O staining to reveal triglycerides: the cells were fixed in 10% formalin for 1 hr, washed twice with H 2 O, allowed to air dry, and then stained with oil red O for about 30 min at room temperature.
Ectopic Bone Formation
Bone-marrow-derived MSCs (2 3 10 6 ) were mixed overnight with carrier particles of ceramic HA-TCP (40 mg; Bio-lu Biomaterials Company), and this mixture was implanted subcutaneously under the dorsal skin of nude mice. After 4 or 8 weeks, mice were euthanized, and the harvested particles were fixed in 4% paraformaldehyde overnight. The particles were analyzed by mCT and stained with H&E and embedded in paraffin for preparing thin sections.
Lentivirus Transfection
The lentivirus particles for knocking down SHP1 protein were purchased from GeneChem. MSCs were infected with the described lentiviral vectors in lowglucose DMEM supplemented with 10 mg/ml polybrene (GeneChem). After transfection, MSCs were selected in medium containing puromycin.
Flow-Cytometric Analysis
Cells were harvested after trypsinization and stained with fluorophore-conjugated antibodies for 30 min on ice. The cell samples were analyzed using a BD FACSCalibur flow cytometer (BD Biosciences). FlowJo software was used for data analysis.
WB
MSCs were scraped off the culture surface and lysed using RIPA lysis buffer (BeyoTime) on ice. Total protein concentration was measured with the BCA protein assay kit (Bio-Rad). Protein samples were separated by SDS-PAGE and transferred to a nitrocellulose membrane, which was then blocked with 5% fat-free milk. Blots were incubated with specific primary antibodies followed by anti-rabbit-HRP (horseradish peroxidase), and staining was detected with the ECL system (Millipore).
Real-Time PCR Total RNA was extracted using TRIzol (Invitrogen). First-strand cDNA was synthesized using the cDNA Synthesizing Kit (Takara) according to the manufacturer's instructions. cDNA was applied as a template to determine the expression of specific genes in real-time PCR with SYBR Green reagent from Takara. Gene expression was normalized to endogenous b-actin mRNA.
Statistical Analysis
Statistical analysis was performed using Prism 5.0 software (GraphPad). Unpaired two-tailed Student's t test was used in all instances, and statistical significance is reported as follows: ns, not significant; *p < 0.05; **p < 0.01; ***p < 0.001. Bars represent means ± SEM.
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